| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |